Details for New Drug Application (NDA): 215168
✉ Email this page to a colleague
The generic ingredient in FLYRCADO is flurpiridaz f-18. Additional details are available on the flurpiridaz f-18 profile page.
Summary for 215168
Tradename: | FLYRCADO |
Applicant: | Ge Hlthcare |
Ingredient: | flurpiridaz f-18 |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 5-55mCi/ML | ||||
Approval Date: | Sep 27, 2024 | TE: | RLD: | Yes |
Complete Access Available with Subscription